# ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding)

> **NCT01628068** · PHASE3 · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 120 (estimated)

## Conditions studied

- Adverse Reaction to Drugs Affecting the Gastrointestinal System

## Interventions

- **DEVICE:** Left atrial appendage occlusion

## Key facts

- **NCT ID:** NCT01628068
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-07
- **Final completion:** 2014-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01628068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01628068, "ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01628068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*